March 5, 2026: Rybelsus Manufacturer, Novo Nordisk, Cited for Not Reporting Adverse Drug Events to FDA The FDA has sent a warning letter to Novo Nordisk because it says the companys written policies for tracking, reporting, and evaluating postmarketing adverse drug experiences to the FDA were insufficient
K.MurzilliS.PoggiA.et al (2009)
This serum won't dry out your skin and is definitely the best choice for whitening and skincare
Ozempic is licensed primarily to manage type 2 diabetes, while Wegovy is licensed specifically for weight loss
doi: 10.3389/fpsyt.2025.1626103 Received 13 May 2025 Accepted 27 October 2025 Published 17 November 2025 Volume 16 - 2025 Edited by Luciane Cruz Lopes, University of Sorocaba, Brazil Reviewed by Raffaele Carraro, La Princesa University Hospital, Spain Kyle Valentino, University of Toronto, Canada Updates Copyright 2025 Yu, Huang, Lo, Huang, Yang and Kornelius